CVS
CVS Health Corp
87.60$
-1.4%
vs. previous close
Closing price · As of: Sep 21, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 35.0% | 31.5% | 32.9% | 32.8% | 23.0% | 22.6% | 24.4% | 25.8% | 28.8% | 27.2% | 27.1% | 28.6% | |
| 3.3% | 2.7% | 3.6% | 1.8% | 2.1% | 2.6% | 3.4% | 4.0% | 5.7% | 3.3% | 3.4% | 3.3% | |
| 3.4% | 2.8% | 3.7% | 1.9% | 3.3% | 3.6% | 4.7% | 5.4% | 6.9% | 4.6% | 4.3% | 4.1% | |
| 13.1% | 12.9% | 12.9% | 13.9% | 9.0% | 8.8% | 9.4% | 10.5% | 11.9% | 14.1% | 14.4% | 15.2% | |
| 16.1% | 15.1% | 15.6% | 16.1% | 8.4% | 7.9% | 8.0% | 7.6% | 8.4% | 7.2% | 7.2% | 7.4% | |
| 11.9% | 10.7% | 10.8% | 10.8% | 5.8% | 14.8% | 5.5% | 5.5% | 5.6% | 12.2% | 11.4% | 10.7% | |
| 37.9% | 41.2% | 40.5% | 40.4% | 40.0% | 35.9% | 34.5% | 34.0% | 34.2% | 36.5% | 36.0% | 32.7% | |
| 13.2% | 15.0% | 14.3% | 14.3% | 18.6% | 14.9% | 13.5% | 12.5% | 10.9% | 11.7% | 10.8% | 9.8% | |
| 48.8% | 59.8% | 61.0% | 60.4% | 70.2% | 71.2% | 69.8% | 67.6% | 68.6% | 69.3% | 70.1% | 71.1% | |
| 25.6% | 25.1% | 27.8% | 32.2% | 22.4% | 24.0% | 26.9% | 29.1% | 30.4% | 31.7% | 33.4% | 34.0% | |
| 1.7% | 1.3% | 2.0% | 5.1% | 1.0% | 2.4% | 3.1% | 2.5% | 1.5% | 1.9% | 3.0% | 2.2% | |
| 8.8% | 8.1% | 8.4% | 9.3% | 4.5% | 4.7% | 4.8% | 5.4% | 6.5% | 6.0% | 6.3% | 22.7% | |
| 15.8% | 28.4% | 27.1% | 23.3% | 36.4% | 29.1% | 25.7% | 22.3% | 22.1% | 23.5% | 23.9% | 23.2% | |
| 51.2% | 40.2% | 39.0% | 39.6% | 29.6% | 28.7% | 30.1% | 32.2% | 31.3% | 30.6% | 29.8% | 28.8% | |
| 42.9% | 38.4% | 41.3% | 45.8% | 20.8% | 20.3% | 21.5% | 23.6% | 24.7% | 24.7% | 24.8% | 23.4% | |
| 1.6% | 1.2% | 1.1% | 1.1% | 0.5% | 0.6% | 0.6% | 0.6% | 0.6% | 0.5% | 0.5% | 0.5% |
Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.